Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

RECURSION PHARMACEUTICALS, INC. (RXRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 59,794 shares @ $7.2085, valued at $431k
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
10/05/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.2907, valued at $64.8k
10/04/2023 4 Dar Zavain (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 1,920 shares @ $0
10/04/2023 4 CHAVEZ R. MARTIN (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 2,619 shares @ $0
10/04/2023 4 Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 1,659 shares @ $0
Gifted 627,705 shares @ $0
10/02/2023 4 Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 3,000 shares @ $7.7198, valued at $23.2k
Exercised 3,000 options to buy @ $1.06, valued at $3.2k
08/24/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $8.9118, valued at $79.2k
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 10,000 shares @ $0
Gifted 10,000 shares @ $0
Converted 10,000 options to buy @ $0
08/10/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 14,498 shares @ $11.0255, valued at $159.8k
Sold 3,272 shares @ $11.7468, valued at $38.4k
08/04/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 60,955 shares @ $13.0171, valued at $793.5k
Sold 4,060 shares @ $13.3631, valued at $54.3k
Exercised 8,674 options to buy @ $11.4, valued at $98.9k
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/27/2023 4 Virani Shafique (Chief Business Officer) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 20,000 shares @ $14.3, valued at $286k
Sold 20,000 shares @ $14.41, valued at $288.2k
Exercised 20,000 options to buy @ $2.22, valued at $44.4k
Exercised 20,000 options to buy @ $2.22, valued at $44.4k
07/27/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Gifted 14,000 shares @ $0
Sold 18,719 shares @ $14.6089, valued at $273.5k
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $6.8873, valued at $61.2k
07/06/2023 4 Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 1,609 shares @ $0
07/06/2023 4 Dar Zavain (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 1,863 shares @ $0
07/06/2023 4 CHAVEZ R. MARTIN (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 2,541 shares @ $0
07/06/2023 4 Bogue Zachary (10% Owner) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 1,440 shares @ $0
07/03/2023 4 Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 3,000 shares @ $7.49, valued at $22.5k
Exercised 3,000 options to buy @ $1.06, valued at $3.2k
06/29/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 8,885 shares @ $7.3876, valued at $65.6k
06/16/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 10,000 shares @ $0
Gifted 10,000 shares @ $0
Converted 10,000 options to buy @ $0
06/15/2023 4 Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 15,485 shares @ $9.9778, valued at $154.5k
06/15/2023 4 Secora Michael (CFO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 25,000 shares @ $9.9323, valued at $248.3k
Sold 25,000 shares @ $10.0735, valued at $251.8k
Exercised 37,500 options to buy @ $2.22, valued at $83.3k
Exercised 37,500 options to buy @ $2.22, valued at $83.3k
06/09/2023 4 Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Sold 56,436 shares @ $9.0511, valued at $510.8k
Exercised 31,250 options to buy @ $2.48, valued at $77.5k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy